Earnings Call · Q4 FY2022·2023-03-01

Q4 22EPS -55.56%·Rev n/aQ3 22EPS +44.23%·Rev n/aQ2 22EPS +100.00%*·Rev n/aQ1 22EPS +100.00%*·Rev n/a⚠ consensus missing

agilon health, inc. AGL

Matthew Gillmor — Vice President of Investor Relations

Steve Sell — Chief Executive Officer

Tim Bensley — Chief Financial Officer

+16.0%1d on move date+15.2% vs SPY3d+15.5%5d+15.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AGL calls or request research access.

More AGL calls Browse calls Request research access